Lead Product(s) : Undisclosed
Therapeutic Area : Genetic Disease
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Sail Biomedicines Updates Collaboration with CFF and Pioneering Medicines
Details : eRNA therapeutic encoding functional full-length cystic fibrosis transmembrane conductance regulator (CFTR) protein. It is being evaluated in preclinical development for Cystic Fibrosis.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 01, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Genetic Disease
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable